Burden of infection and fat mass in healthy middle-aged men

Obesity

Volumn 15, Issue 1, 2007, Pages 245-252

  Fernández Real, José Manuel ^a   Ferri, Maria José ^a   Vendrell, Joan ^b   Ricart, Wifredo ^a  

^a GIRONA BIOMEDICAL RESEARCH INSTITUTE IDIBGI   (Spain)

^b HOSPITAL UNIVERSITARI JOAN XXIII   (Spain)

Author keywords

Cytokines; Fat mass; Inflammation; Insulin action

Indexed keywords

BACTERIUM ANTIBODY; VIRUS ANTIBODY;

ADIPOSE TISSUE; ARTICLE; BACTERIAL INFECTION; BLOOD; CHLAMYDOPHILA PNEUMONIAE; COST OF ILLNESS; ECONOMICS; ENTEROVIRUS INFECTION; ENZYME LINKED IMMUNOSORBENT ASSAY; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; IMMUNOLOGY; IMPEDANCE; INFLAMMATION; MALE; METABOLISM; MIDDLE AGED; QUALITY OF LIFE;

ADIPOSE TISSUE; ANTIBODIES, BACTERIAL; ANTIBODIES, VIRAL; CHLAMYDOPHILA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; COST OF ILLNESS; ELECTRIC IMPEDANCE; ENTEROVIRUS INFECTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; HERPESVIRUS 2, HUMAN; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; QUALITY OF LIFE;

CHLAMYDOPHILA PNEUMONIAE; ENTEROVIRUS; HUMAN HERPESVIRUS 1; HUMAN HERPESVIRUS 2;

EID: 33846880906     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2007.541     Document Type: Article

References (45)

1. Ridker PM, Buring JE, Cook NR, Rifai N. C-reactive protein, the metabolic syndrome, and risk of incident cardio-vascular events: an 8-year follow-up of 14,719 initially healthy American women. Circulation. 2003;107:391-7.
2. Pickup JC, Mattock MB, Chusney GD, Burt D. NIDDM as a disease of the innate immune system: association of the acute-phase reactants and interleukin 6 with metabolic syndrome X. Diabetologia. 1997;40:1286-92.
3. Pickup JC, Crook MA. Is type II diabetes a disease of the innate immune system? Diabetologia. 1998;41:1241-8.
4. Fernández-Real JM, Ricart W. Insulin resistance and inflammation in an evolutionary perspective. The contribution of cytokine genotype/phenotype to thriftiness. Diabetologia. 1999;42:1367-74.
5. Fernández-Real JM, Ricart W. Insulin resistance and chronic cardiovascular inflammatory syndrome. Endocr Rev. 2003;24:278-301.
6. Dandona P, Aljada A, Chaudhuri A, Mohanty P, Garg R. Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation. 2005;111:1448-54.
7. Yudkin JS, Kumari M, Humphries SE, Mohamed-Ali V. Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? Atherosclerosis. 2000;148:209-14.
8. Visser MR, Tracy PB, Vercellotti GM, Goodman JL, White JG, Jacob HS. Enhanced thrombin generation and platelet binding on herpes simplex virus-infected endothelium. Proc Natl Acad Sci USA. 1999;85:8227-30.
9. Key NS, Vercellotti GM, Winkelmann JC, et al. Infection of vascular endothelial cells with herpes simplex virus enhances tissue factor activity and reduces thrombomodulin expression. Proc Natl Acad Sci USA. 1990;87:7095-9.
10. Kol A, Sukhova GK, Lichtman AH, Libby P. Chlamydial heat shock protein 60 localizes in human atheroma and regulates macrophage tumor necrosis factor- and matrix metalloproteinase expression. Circulation. 1998;98:300-7.
11. Dechend R, Maass M, Gieffers J, et al. Chlamydia pneumoniae infection of vascular smooth muscle and endothelial cells activates NF-B and induces tissue factor and PAI-1 expression: a potential link to accelerated arteriosclerosis. Circulation. 1999;100:1369-73.
12. Lyons MJ, Faust IM, Hemmes RB, Buskirk DR, Hirsch J, Zabriskie JB. A virally induced obesity syndrome in mice. Science. 1982;216:82-5.
13. Bernard A, Zwingelstein G, Meister R, Fabian Wild T. Hyperinsulinemia induced by canine distemper virus infection of mice and its correlation with the appearance of obesity. Comp Biochem Physiol. 1988;91B:691-6.
14. Carter JK, Garlich JD, Donaldson WT, Smith RE. Influence of diet on a retrovirus induced obesity and stunting syndrome. Avian Dis. 1983;27:317-22.
15. Gosztonyi G, Ludwig H. Borna disease: neuropathology and pathogenesis. Curr Topics Microbiol Immunol. 1995;190:39- 73.
16. Atkinson RL, Dhurandhar NV, Allison DB, et al. Human adenovirus-36 is associated with increased body weight and paradoxical reduction of serum lipids. Int J Obes Relat Metab Disord. 2005;29:281-6.
17. Epstein SE, Zhou YF, Zhu J. Infection and atherosclerosis: emerging mechanistic paradigms. Circulation. 1999;100:e20-8.
18. Zhu J, Nieto FJ, Home BD, Anderson JL, Muhlestein JB, Epstein SE. Prospective study of pathogen burden and risk of myocardial infarction or death. Circulation. 2001;103:45-51.
19. Prasad A, Zhu J, Halcox JPJ, Waclawiw MA, Epstein SE, Quyyumi AA. Predisposition to atherosclerosis by infections. Role of endothelial dysfunction. Circulation. 2002;106:184-90.
20. Epstein SE. The multiple mechanisms by which infection may contribute to atherosclerosis development and course. Circ Res. 2002;90:2-4.
21. Espinola-Klein C, Rupprecht HJ, Blankenberg S, et al. and AtheroGene Investigators. Impact of infectious burden on extent and long-term prognosis of atherosclerosis. Circulation. 2002;105:15-21.
22. Smieja M, Gnarpe J, Lonn E, et al. and Heart Outcomes Prevention Evaluation (HOPE) Study Investigators. Multiple infections, subsequent cardiovascular events, and atherosclerotic progression in the Heart Outcome and Prevention Evaluation (HOPE) Study. Circulation. 2003;107: 251-7.
23. Pussinen PJ, Nyyssonen K, Alfthan G, Salonen R, Laukkanen JA, Salonen JT. Serum antibody levels to Actinobacillus actinomycetemcomitans predict the risk for coronary heart disease. Arterioscler Thromb Vasc Biol. 2005;25:833-88.
24. Toplak H, Wascher TC, Weber K, et al. Increased prevalence of serum IgA Chlamydia antibodies in obesity. Acta Med Austriaca. 1995;22:23-4.
25. Ekesbo R, Nilsson PM, Lindholm LH, Persson K, Wadstrom T. Combined seropositivity for H. pylori and C. pneumoniae is associated with age, obesity and social factors. J Cardiovasc Risk. 2003;7:191-5.
26. Leinonen M, Saikku P. Interaction of Chlamydia pneumoniae infection with other risk factors of atherosclerosis. Am Heart J. 1999;138:S504-6.
27. Laurila A, Bloigu A, Nayha S, Hassi J, Leinonen M, Saikku P. Chronic Chlamydia pneumoniae infection is associated with a serum lipid profile known to be a risk factor for atherosclerosis. Arterioscler Thromb Vasc Biol. 1997;17:2910-3.
28. Murray LJ, O'Reilly DP, Ong GM, O'Neill C, Evans AE, Bamford KB. Chlamydia pneumoniae antibodies are associated with an atherogenic lipid profile. Heart. 1999;8:239-44.
29. Muller J, Moller DS, Kjaer M, Nyvad O, Larsen NA, Pedersen EB. Chlamydia pneumoniae DNA in peripheral blood mononuclear cells in healthy control subjects and patients with diabetes mellitus, acute coronary syndrome, stroke, and arterial hypertension. Scand J Infect Dis. 2003;35:704-12.
30. Falck G, Gnarpe J, Hansson LO, Svardsudd K, Gnarpe H. Comparison of individuals with and without specific IgA antibodies to Chlamydia pneumoniae: respiratory morbidity and the metabolic syndrome. Chest. 2002;122:1587-93.
31. Kristensen BO, Andersen PL, Vestergaard BF, Andersen HM. Herpesvirus antibodies and vascular complications in essential hypertension. Acta Med Scand. 1982;212:375-7.
32. Sun Y, Pei W, Wu Y, Yang Y. An association of herpes simplex virus type 1 infection with type 2 diabetes. Diabetes Care. 2005;28:435-6.
33. Sun Y, Pei W, Wu Y, Jing Z, Zhang J, Wang G. Herpes simplex virus type 2 infection is a risk factor for hypertension. Hypertens Res. 2004;27:541-4.
34. Roberts BW, Cech I. Association of type 2 diabetes mellitus and seroprevalence for cytomegalovirus. South Med J. 2005;98:686-92.
35. Roivainen M, Alfthan G, Jousilahti P, Kimpimaki M, Hovi T, Tuomilehto J. Enterovirus infections as a possible risk factor for myocardial infarction. Circulation. 1998;98:2534-7.
36. Xu F, Schillinger J, Sternberg M, et al. Seroprevalence and coinfection with herpes simplex virus type 1 and type 2 in the United States, 1988-1994. J Infect Dis. 2002;185:1019-24.
37. Cook PJ, Honeybourne D. Clinical aspects of Chlamydia pneumoniae infection. Presse Med. 1995;24:278-82.
38. Finch CE, Crimmins EM. Inflammatory exposure and historical changes in human life-spans. Science. 2004;305:1736-9.
39. Tanaka SI, Inoue S, Isoda F, et al. Impaired immunity in obesity: suppressed but reversible lymphocyte responsiveness. Int J Obes Relat Metab Disord. 1993;17:631-6.
40. Greenway F. Virus-induced obesity. Am J Physiol Regul Integr Comp Physiol. 2006;290:R188-9.
41. Khanna KM, Lepisto AJ, Decman V, Hendricks RL. Immune control of herpes simplex virus during latency. Curr Opin Immunol. 2004;16:463-9.
42. Ward ME. The immunobiology and immunopathology of chlamydial infections APMIS. 1995;103:769-96.
43. Beatty WL, Morrison RP, Byrne GI. Persistent chlamydiae: from cell culture to a paradigm for chlamydial pathogenesis. Microbiol Rev. 1994;58:686-99.
44. Frisk G. Mechanisms of chronic enteroviral persistence in tissue. Curr Opin Infect Dis. 2001;14:251-6.
45. Harvala H, Kalimo H, Dahllund L, et al. Mapping of tissue tropism determinants in coxsackievirus genomes. J Gen Virol. 2002;83:1697-706.